SLC36A4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.296000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.491000E-01
Normal-vs-Stage2
9.237600E-01
Normal-vs-Stage3
2.214400E-01
Normal-vs-Stage4
5.810200E-01
Stage1-vs-Stage2
5.432400E-02
Stage1-vs-Stage3
1.101190E-01
Stage1-vs-Stage4
2.082800E-01
Stage2-vs-Stage3
2.572800E-01
Stage2-vs-Stage4
5.385800E-01
Stage3-vs-Stage4
6.974000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.604400E-01
Normal-vs-AfricanAmerican
6.063800E-01
Normal-vs-Asian
2.908800E-01
Caucasian-vs-AfricanAmerican
8.130600E-01
Caucasian-vs-Asian
2.110000E-02
AfricanAmerican-vs-Asian
7.230000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.998800E-01
Normal-vs-Female
2.886000E-01
Male-vs-Female
4.998000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.056200E-01
Normal-vs-Age(41-60Yrs)
9.012100E-02
Normal-vs-Age(61-80Yrs)
8.483200E-01
Normal-vs-Age(81-100Yrs)
5.364600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.991800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.592400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.721220E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.196570E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.721600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.218200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.836800E-01
Normal-vs-Daily Drinker
8.569600E-01
Normal-vs-Weekly Drinker
3.859400E-01
Normal-vs-Occasional Drinker
2.703400E-01
Normal-vs-Social Drinker
1.564190E-01
Non Drinker-vs-Daily Drinker
5.256600E-01
Non Drinker-vs-Weekly Drinker
8.394200E-01
Non Drinker-vs-Occasional Drinker
1.246230E-01
Non Drinker-vs-Social Drinker
6.179700E-02
Daily Drinker-vs-Weekly Drinker
4.739200E-01
Daily Drinker-vs-Occasional Drinker
2.195800E-01
Daily Drinker-vs-Social Drinker
1.260630E-01
Weekly Drinker-vs-Occasional Drinker
1.058620E-01
Weekly Drinker-vs-Social Drinker
5.161700E-02
Occasional Drinker-vs-Social Drinker
8.810600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.743800E-01
Normal-vs-Grade 2
1.707230E-01
Normal-vs-Grade 3
1.618350E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.780300E-02
Grade 1-vs-Grade 3
5.572400E-02
Grade 1-vs-Grade 4
2.743800E-01
Grade 2-vs-Grade 3
4.935200E-01
Grade 2-vs-Grade 4
1.707230E-01
Grade 3-vs-Grade 4
1.618350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.660200E-01
Normal-vs-NonDiabetic
4.725600E-01
Diabetic-vs-NonDiabetic
4.345000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.527200E-01
Normal-vs-NoPancreatitis
5.393600E-01
Pancreatitis-vs-NoPancreatitis
3.264400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.539230E-01
Normal-vs-N1
9.305600E-01
N0-vs-N1
1.009180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.007150E-01
Normal-vs-TP53-NonMutant
7.082300E-02
TP53-Mutant-vs-TP53-NonMutant
3.156400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
